Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Google News
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Canada Finance
Sage Therapeutics (NASDAQ:SAGE) PT Lowered to $17.00 - MarketBeat
Sage Therapeutics (NASDAQ:SAGE) Given Hold Rating at Needham & Company LLC - MarketBeat
Scotiabank cuts Sage Therapeutics shares target after Phase 2 trial setback By Investing.com - Investing.com
Scotiabank cuts Sage Therapeutics shares target after Phase 2 trial setback - Investing.com Canada
In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics - Sage Therapeutics (NASDAQ:SAGE) - Benzinga
Sage Therapeutics Stock: Reassessing Investment Post Parkinson's Failure - Seeking Alpha
Sage Therapeutics Stock: Reassessing Investment Post Parkinson's Failure - Seeking Alpha
Sage Therapeutics (SAGE) PT Lowered to $19 at Scotiabank - StreetInsider.com
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »
×